Tower Research Capital (TRC)’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $15K | Buy |
|
|||||
|
2022
Q1 | $0 | Buy |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $26K | Buy |
|
|||||
|
2021
Q2 | $13K | Sell |
|
|||||
|
2021
Q1 | $13K | Sell |
|
|||||
|
2020
Q4 | $33K | Sell |
|
|||||
|
2020
Q3 | $58K | Buy |
|
|||||
|
2020
Q2 | $14K | Buy |
|
|||||
|
2020
Q1 | $3K | Buy |
|
|||||
|
2019
Q4 | $2K | Sell |
|
|||||
|
2019
Q3 | $7K | Buy |
|
|||||
|
2019
Q2 | $6K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1K | Buy |
|